SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
TRVN
--
0.00%
--
Hedge Funds Never Been Less Bullish On Trevena Inc (TRVN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are
Insider Monkey · 8h ago
Company News for June 3, 2020
Zacks · 1d ago
Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.
GlobeNewswire · 1d ago
Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.
CHESTERBROOK, Pa., June 03, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous
Benzinga · 1d ago
Why Trevena's Stock Is Trading Higher Today
Benzinga · 2d ago
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Tenax Therapeutics Inc (NASDAQ: TENX) shares climbed 42.3% to $2.07 after the company reported results from its Phase 2 trial of Levosimendan. The trial demonstrated a significant reduction in right atrial and pulmonary capillary wedge pressures.
Benzinga · 2d ago
Why Trevena's Stock Is Trading Higher Today
Trevena (NASDAQ: TRVN) shares are trading higher on Tuesday. The company announced a collaboration agreement with Imperial College London to evaluate its TRV027 drug in coronavirus patients.
Benzinga · 2d ago
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
GlobeNewswire · 2d ago
Stocks That Hit 52-Week Highs On Wednesday
This morning 30 companies set new 52-week highs.
Benzinga · 05/27 14:39
Is Trevena (TRVN) Outperforming Other Medical Stocks This Year?
Zacks · 05/22 16:30
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning trading, 59 companies set new 52-week highs.
Benzinga · 05/19 14:43
Trevena (TRVN) Investor Presentation - Slideshow
Seeking Alpha - Article · 05/19 12:08
Trevena, Inc. (TRVN) CEO Carrie Bourdow on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/07 16:47
Trevena Reports First Quarter 2020 Results
GlobeNewswire · 05/07 12:00
Trevena Q1 EPS $(0.060), Inline
Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.060) per share which met the analyst consensus estimate. This is unchanged from the same period last year.
Benzinga · 05/07 11:38
Has Trevena, Inc.(TRVN) Outpaced Other Medical Stocks This Year?
Zacks · 05/06 16:30
Trevena to Release First Quarter 2020 Financial Results on May 7, 2020
GlobeNewswire · 05/01 12:00
Trevena Announces Publication of Comprehensive Review of Oliceridine Data
GlobeNewswire · 04/23 12:00
Trevena Highlights Publication Of Review Of Oliceridine Data
Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the publication of a
Benzinga · 04/23 11:05
3 Biotech Stocks Under $2 With Massive Upside Potential
TipRanks · 04/12 12:01